loadpatents
Patent applications and USPTO patent grants for KEANEY; Gregg F..The latest application filed is for "pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same".
Patent | Date |
---|---|
Pharmaceutical Compositions Of A Selective C-kit Kinase Inhibitor And Methods For Making And Using Same App 20220184045 - KEANEY; Gregg F. ;   et al. | 2022-06-16 |
Crystalline Forms Of A Selective C-kit Kinase Inhibitor App 20220056026 - Keaney; Gregg F. ;   et al. | 2022-02-24 |
Heteroaromatic Nmda Receptor Modulators And Uses Thereof App 20210403474 - Anderson; David R. ;   et al. | 2021-12-30 |
Crystalline Forms Of Potassium Channel Modulators App 20210395229 - Keaney; Gregg F. ;   et al. | 2021-12-23 |
Potassium Channel Modulators App 20210380571 - Amrutkar; Dipak Vasantrao ;   et al. | 2021-12-09 |
Certain Pladienolide Compounds And Methods Of Use App 20210163456 - KEANEY; Gregg F. ;   et al. | 2021-06-03 |
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use App 20200361915 - Keaney; Gregg F. ;   et al. | 2020-11-19 |
Potassium channel modulators Grant 10,774,064 - Eriksen , et al. Sept | 2020-09-15 |
Heteroaromatic NMDA receptor modulators and uses thereof Grant 10,752,633 - Anderson , et al. A | 2020-08-25 |
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pi- ridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-- 1-carboxylate and methods of use thereof Grant 10,745,387 - Keaney , et al. A | 2020-08-18 |
Potassium channel modulators Grant 10,717,728 - Amrutkar , et al. | 2020-07-21 |
Heteroaromatic Nmda Receptor Modulators And Uses Thereof App 20200131190 - Anderson; David R. ;   et al. | 2020-04-30 |
Heteroaromatic NMDA receptor modulators and uses thereof Grant 10,584,131 - Anderson , et al. | 2020-03-10 |
Heteroaromatic Nmda Receptor Modulators And Uses Thereof App 20200039987 - Anderson; David R. ;   et al. | 2020-02-06 |
Potassium Channel Modulators App 20190352293 - Amrutkar; Dipak Vasantrao ;   et al. | 2019-11-21 |
Potassium Channel Modulators App 20190218200 - Eriksen; Birgitte Langer ;   et al. | 2019-07-18 |
Potassium channel modulators Grant 10,351,553 - Amrutkar , et al. July 16, 2 | 2019-07-16 |
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use App 20190100513 - Keaney; Gregg F. ;   et al. | 2019-04-04 |
Potassium Channel Modulators App 20180215746 - Amrutkar; Dipak Vasantrao ;   et al. | 2018-08-02 |
Methods For The Treatment Of Tremors By Positive Modulation Of Sk Channels App 20180207138 - Amrutkar; Dipak Vasantrao ;   et al. | 2018-07-26 |
Potassium channel modulators Grant 9,975,886 - Amrutkar , et al. May 22, 2 | 2018-05-22 |
Enzymatic transamination of cyclopamine analogs Grant 9,879,293 - Austad , et al. January 30, 2 | 2018-01-30 |
Potassium Channel Modulators App 20170355708 - Jefson; Martin R. ;   et al. | 2017-12-14 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20170119734 - Bahadoor; Adilah ;   et al. | 2017-05-04 |
Pladienolide pyridine compounds and methods of use Grant 9,481,669 - Keaney , et al. November 1, 2 | 2016-11-01 |
Enzymatic Transamination Of Cyclopamine Analogs App 20160177354 - Austad; Brian C. ;   et al. | 2016-06-23 |
Tetrazolones as inhibitors of fatty acid synthase Grant 9,346,769 - Bahadoor , et al. May 24, 2 | 2016-05-24 |
Pladienolide Pyridine Compounds and Methods of Use App 20150329528 - Keaney; Gregg F. ;   et al. | 2015-11-19 |
Enzymatic Transamination of Cyclopamine Analogs App 20140371456 - Austad; Brian C. ;   et al. | 2014-12-18 |
Enzymatic transamination of cyclopamine analogs Grant 8,703,448 - Austad , et al. April 22, 2 | 2014-04-22 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20140079667 - BAHADOOR; Adilah ;   et al. | 2014-03-20 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,609,706 - Castro , et al. December 17, 2 | 2013-12-17 |
Tetrazolones as inhibitors of fatty acid synthase Grant 8,546,432 - Bahadoor , et al. October 1, 2 | 2013-10-01 |
Triazoles As Inhibitors Of Fatty Acid Synthase App 20130243727 - BAHADOOR; Adilah ;   et al. | 2013-09-19 |
Triazoles as inhibitors of fatty acid synthase Grant 8,450,350 - Bahadoor , et al. May 28, 2 | 2013-05-28 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20130131063 - Castro; Alfredo C. ;   et al. | 2013-05-23 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,178,690 - Castro , et al. May 15, 2 | 2012-05-15 |
Enzymatic Transamination of Cyclopamine Analogs App 20120083607 - Austad; Brian c. ;   et al. | 2012-04-05 |
Triazoles As Inhibitors Of Fatty Acid Synthase App 20110274654 - BAHADOOR; Adilah ;   et al. | 2011-11-10 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20110274655 - BAHADOOR; Adilah ;   et al. | 2011-11-10 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20110213145 - Castro; Alfredo C. ;   et al. | 2011-09-01 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,928,244 - Castro , et al. April 19, 2 | 2011-04-19 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20080114167 - CASTRO; Alfredo C. ;   et al. | 2008-05-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.